Miguel Martin

Miguel Martin

UNVERIFIED PROFILE

Are you Miguel Martin?   Register this Author

Register author
Miguel Martin

Miguel Martin

Publications by authors named "Miguel Martin"

Are you Miguel Martin?   Register this Author

99Publications

3375Reads

12Profile Views

Influence of rainfall intensity and pollution build-up levels on water quality and quantity response of permeable pavements.

Sci Total Environ 2019 Sep 21;684:303-313. Epub 2019 May 21.

Instituto de Ingeniería del Agua y Medio Ambiente, Universitat Politècnica de València, Camino de Vera s/n, 46022, Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2019.05.271DOI Listing
September 2019

Small GTPases of the Ras superfamily and glycogen phosphorylase regulation in T cells.

Small GTPases 2019 Sep 12:1-8. Epub 2019 Sep 12.

Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU , Leioa , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21541248.2019.1665968DOI Listing
September 2019

Depression and psychosis related to the absence of visitors and consumption of drugs in male prisoners in Ecuador: a cross sectional study.

BMC Psychiatry 2019 Aug 7;19(1):248. Epub 2019 Aug 7.

School of Medicine, Universidad Internacional del Ecuador, Av. Jorge Fernández s/n and Simon Bolívar, 170113, Quito, Ecuador.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12888-019-2227-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686258PMC
August 2019

High Rates of Exposures to Waterborne Pathogens in Indigenous Communities in the Amazon Region of Ecuador.

Am J Trop Med Hyg 2019 Jul;101(1):45-50

Unidad de Bioestadística, Facultad de Medicina, Universidad Autónoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4269/ajtmh.18-0970DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609175PMC
July 2019

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval.

Oncotarget 2019 Jul 2;10(42):4321-4332. Epub 2019 Jul 2.

Medical Oncology Service, Hospital del Mar, IMIM, Universitat Pompeu Fabra, The Centre of Networked Biomedical Cancer Research (CIBERONC), and Centro Oncológico Clara Campal-HM Delfos, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/27039
Publisher Site
http://dx.doi.org/10.18632/oncotarget.27039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611514PMC
July 2019

Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts.

FASEB J 2019 Jun 8;33(6):7168-7179. Epub 2019 Mar 8.

Research Group on Neuromuscular and Mitochondrial Disorders, Vall d'Hebron Institut de Recerca-Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.201801591RDOI Listing
June 2019

Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement.

Oncologist 2019 May 1;24(5):603-611. Epub 2019 Feb 1.

Department of Medical Oncology and Hematology, Hospital Clínico Universitario, University of Valencia-INCLIVA Health Research Institute, CIBERONC, Valencia, Spain.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0228DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516119PMC
May 2019

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.

Invest New Drugs 2019 02 9;37(1):98-108. Epub 2018 Jun 9.

Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, C/Dr. Esquerdo 46, 28009, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0614-9DOI Listing
February 2019

[Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].

Rev Esp Patol 2018 Jul - Sep;51(3):154-159. Epub 2017 Nov 15.

Servicio de Oncología Médica, Complejo Hospitalario de Navarra, Pamplona, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.patol.2017.10.003DOI Listing
February 2019

Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

J Inherit Metab Dis 2018 11 20;41(6):1027-1035. Epub 2018 Jun 20.

Grup de Recerca en Malalties Neuromusculars i Neuropediatriques, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10545-018-0203-2
Publisher Site
http://dx.doi.org/10.1007/s10545-018-0203-2DOI Listing
November 2018

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

J Inherit Metab Dis 2018 Nov;41(6):1295

Grup de Recerca en Malalties Neuromusculars i Neuropediatriques, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Campus Can Ruti, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-018-0236-6DOI Listing
November 2018

Simulation modeling approaches to answer clinically relevant questions in breast cancer low-risk populations.

Ann Transl Med 2018 Nov;6(Suppl 1):S80

Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.10.68DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291602PMC
November 2018

Missense mutations have unexpected consequences: The McArdle disease paradigm.

Hum Mutat 2018 10 26;39(10):1338-1343. Epub 2018 Jul 26.

Grupo de Investigación de Enfermedades Mitocondriales y Neuromusculares, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/humu.23591
Publisher Site
http://dx.doi.org/10.1002/humu.23591DOI Listing
October 2018

Different mitochondrial genetic defects exhibit the same protein signature of metabolism in skeletal muscle of PEO and MELAS patients: A role for oxidative stress.

Free Radic Biol Med 2018 10 20;126:235-248. Epub 2018 Aug 20.

Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Spain; Instituto de Investigación Hospital, 12 de Octubre (i+12), Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08915849183142
Publisher Site
http://dx.doi.org/10.1016/j.freeradbiomed.2018.08.020DOI Listing
October 2018

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.

J Clin Oncol 2018 08 3;36(24):2465-2472. Epub 2018 Jun 3.

Dennis J. Slamon, University of California Los Angeles Medical Center, Santa Monica, CA; Patrick Neven, Multidisciplinary Breast Centre, Universitair Ziekenhuis, Leuven; Guy Jerusalem, Centre Hospitalier Universitaire de Liege and Liege University, Liège, Belgium; Stephen Chia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Peter A. Fasching, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen; Arnd Nusch, Practice for Hematology and Internal Oncology, Velbert, Germany; Michelino De Laurentiis, Istituto Nazionale Tumori "Fondazione G. Pascale," Naples; Giulia Val Bianchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy; Seock-Ah Im, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Katarina Petrakova, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Francisco J. Esteva, New York University Langone Health, New York, NY; Miguel Martín, Instituto de Investigacion Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid; Luis De la Cruz-Merino, Hospital Universitario Virgen Macarena, Seville, Spain; Gabe S. Sonke, Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, the Netherlands; J. Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Xavier Pivot, Institut Régional du Cancer, Strasbourg, France; Gena Vidam, Karen Rodriguez Lorenc, Michelle Miller, and Tetiana Taran, Novartis Pharmaceuticals, East Hanover, NJ; and Yingbo Wang, Novartis Pharma, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.9909
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.9909DOI Listing
August 2018

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

N Engl J Med 2018 08 15;379(8):753-763. Epub 2018 Aug 15.

From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802905DOI Listing
August 2018

The LILAC trial and the blooming of anticancer biosimilars.

Authors:
Miguel Martin

Lancet Oncol 2018 07 4;19(7):861-863. Epub 2018 Jun 4.

Instituto de Investigacion Sanitaria Gregorio Marañon, Ciberonc, Geicam, Universidad Complutense, 28007 Madrid. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045183029
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(18)30290-0DOI Listing
July 2018

Variables to Predict Mortality in Hip Fractures in Patients Over 65 Years of Age: A Study on the Role of Anticoagulation as a Risk Factor.

J Trauma Nurs 2017 Sep/Oct;24(5):326-334

Department of Nursing, University of Cantabria, Cantabria, Spain (Dr Sarabia-Cobo); University of Cantabria, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain (Ms Sáenz-Jalón); and Hospital Universitario Marqués de Valdecilla, Cantabria, Spain (Mss Vélez-Carrera, Miguel Martín, Rodríguez Landeras, Roscales San Bartolomé, Santiago Fernández, Higuero-Piris, Artabe Pozas, Espeso Salas, and Briz Casares).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTN.0000000000000313DOI Listing
June 2018

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

Lancet Oncol 2018 06 26;19(6):812-824. Epub 2018 Apr 26.

Breast Cancer Unit and Gynaecological Tumours, Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Baselga Oncology Institute, Quiron Group, Madrid and Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30147-5DOI Listing
June 2018

First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study.

Breast 2018 Apr 8;38:144-149. Epub 2018 Jan 8.

Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.12.016DOI Listing
April 2018

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

J Clin Oncol 2018 04 14;36(11):1073-1079. Epub 2018 Feb 14.

Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA; Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health; Priya Rastogi, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA; André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec; Alexander H.G. Paterson, Tom Baker Cancer Centre, Calgary, Alberta, Canada; Miguel Martín, CIBERONC, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid; José Manuel Baena-Cañada, Hospital Puerta del Mar, Cádiz, Spain; Johan W.R. Nortier, Leids Universitair Medisch Centrum, Leiden, Netherlands; Mothaffar F. Rimawi, Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St. Gallen; Stefan Aebi, Lucerne Cantonal Hospital and University of Bern, Switzerland; Eleftherios P. Mamounas, Orlando Health University of Florida Health Cancer Center, Orlando, FL; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; and Alan S. Coates, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891132PMC
April 2018

High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease.

Oncotarget 2018 Apr 24;9(31):21893-21903. Epub 2018 Apr 24.

Molecular Pathology and Therapeutic Targets Research Lab, Instituto de Investigación del Hospital Universitario La Paz, IdiPAZ, Hospital Universitario La Paz, HULP, Madrid 28046, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955171PMC
April 2018

Characterization of wash-off from urban impervious surfaces and SuDS design criteria for source control under semi-arid conditions.

Sci Total Environ 2018 Jan 8;612:1320-1328. Epub 2017 Sep 8.

Grupo de Investigación de Tecnología de la Construcción (GITECO), Universidad de Cantabria, Av. de los Castros 44, 39005 Santander, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2017.09.011DOI Listing
January 2018

Biosimilars.

Authors:
Miguel Martin

ESMO Open 2018 24;3(1):e000321. Epub 2018 Jan 24.

Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain.

View Article

Download full-text PDF

Source
http://esmoopen.bmj.com/lookup/doi/10.1136/esmoopen-2018-000
Publisher Site
http://dx.doi.org/10.1136/esmoopen-2018-000321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786913PMC
January 2018

Rhodamine-based sensor for real-time imaging of mitochondrial ATP in living fibroblasts.

Biochim Biophys Acta Bioenerg 2017 Dec 22;1858(12):999-1006. Epub 2017 Sep 22.

Dto. Química Física I, Universidad Complutense de Madrid, Avenida Complutense s/n, 28040 Madrid, Spain; Instituto de Investigación Hospital "12 de Octubre" (i+12), Avenida de Córdoba, s/n, 28041 Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbabio.2017.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656571PMC
December 2017

Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer.

Future Oncol 2017 Oct 31;13(24):2137-2149. Epub 2017 Jul 31.

Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0183DOI Listing
October 2017

Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer.

Breast Care (Basel) 2017 Oct 19;12(5):296-302. Epub 2017 Oct 19.

Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense de Madrid, CiberOnc, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000481656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704690PMC
October 2017

Tuning up adjuvant endocrine therapy: the TEAM trial.

Authors:
Miguel Martin

Lancet Oncol 2017 09 18;18(9):1145-1146. Epub 2017 Jul 18.

Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid 28007, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30462-XDOI Listing
September 2017

Neratinib for the treatment of HER2-positive early stage breast cancer.

Expert Rev Anticancer Ther 2017 08 26;17(8):669-679. Epub 2017 Jun 26.

c Instituto de Investigación Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense, CiberOnc, GEICAM , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1338954DOI Listing
August 2017

Establishment of a human iPSC line (IISHDOi001-A) from a patient with McArdle disease.

Stem Cell Res 2017 08 28;23:188-192. Epub 2017 Jul 28.

Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas "Alberto Sols", (UAM-CSIC) Madrid, Spain; Centro de Investigación Biomédica en Red (CIBERER), Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2017.07.020DOI Listing
August 2017

Muscle fiber type proportion and size is not altered in mcardle disease.

Muscle Nerve 2017 06 16;55(6):916-918. Epub 2016 Dec 16.

Division of Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, PO Box 115, Newlands, 7725, South Africa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.25472DOI Listing
June 2017

Physical activity and breast cancer risk by pathological subtype.

Gynecol Oncol 2017 03 3;144(3):577-585. Epub 2017 Jan 3.

Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Madrid, Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.12.014DOI Listing
March 2017

RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.

J Natl Cancer Inst 2017 03;109(3)

"Sandro Pitigliani" Department of Medical Oncology, Hospital of Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw234DOI Listing
March 2017

Formal and Informal Learning and First-Year Psychology Students' Development of Scientific Thinking: A Two-Wave Panel Study.

Front Psychol 2017 10;8:133. Epub 2017 Feb 10.

Research on Learning and Instruction, Department of Humanities, Social and Political Sciences, ETH Zurich Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fpsyg.2017.00133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301459PMC
February 2017

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

J Clin Oncol 2017 Jan 7;35(2):141-148. Epub 2016 Nov 7.

Edith A. Perez, Mayo Clinic, Jacksonville, FL; Howard Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Jennifer A. Petersen, Genentech, South San Francisco, CA; Carlos Barrios, Pontifícia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil; Wolfgang Eiermann, Interdisciplinary Oncology Center, Munich, Germany; Masakazu Toi, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Young-Hyuck Im, Samsung Medical Centre, Seoul, Korea; Pierfranco Conte, University of Padova and Istituto Oncologico Veneto, Padova, Italy; Miguel Martin, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland; Xavier Pivot, University Hospital Jean Minjoz, Besançon, France; Sven Stanzel, Alexander Strasak, Monika Patre, F. Hoffmann-La Roche, Basel, Switzerland; and Paul Ellis, Guys Hospital and Sarah Cannon Research Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.4887
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.4887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455677PMC
January 2017

Two-Step Amyloid Aggregation: Sequential Lag Phase Intermediates.

Sci Rep 2017 01 9;7:40065. Epub 2017 Jan 9.

Dept. of Physical Chemistry, Faculty of Pharmacy, University of Granada, Cartuja Campus, 18071, Granada Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep40065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220338PMC
January 2017

Palbociclib and Letrozole in Advanced Breast Cancer.

N Engl J Med 2016 11;375(20):1925-1936

From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.), the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.), and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California; Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.); U.S. Oncology Research, The Woodlands, TX (S.J.); Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); British Columbia Cancer Agency, Vancouver, Canada (K.G.); Brustzentrum der Universität München (LMU), Munich, Germany (N.H.); State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.); All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.); M.D. Anderson Cancer Center, University of Texas, Houston (S.M.); and Institut Curie, Paris (V.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607303DOI Listing
November 2016